Skip to main content
finq
OS
Search ticker, company, or fund...
⌘
K
Capture
Closed
BIAF: bioAffinity Technologies, Inc. Stock Analysis | finqOS
Healthcare · Medical - Diagnostics & Research
The Story
BIAF
The Story
BIAF
Loading chart data...
Current State
Balance holding
The verdict
Good business
Weak
Revenue growth
+0.0% / yr
Operating margin
-204.3%
ROIC
-229.2%
Financially safe
Stretched
Debt / equity
0.38×
Interest coverage
-265.1×
Current ratio
1.36×
bioAffinity Technologies, Inc.
BIAF
NASDAQ Capital Market
·
USD
·
Closed
Story
Data
Canvas
Capture
Save
bioAffinity Technologies, Inc.
BIAF
NASDAQ
·
USD
·
Closed
$0.63
−2.64%
$0.63
−$0.02 (2.64%)
52W Range
1th
pctl
Volume
0.28×
avg
Mkt Cap
2.84M
USD
P/E
-0.1
TTM
Div Yield
–
ann
52W Range
1th
pctl
Volume
0.28×
avg
Market Cap
2.84M
USD
P/E Ratio
-0.1
TTM
Div Yield
-
ann
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings